Travelan™
See also a special website: www.travelan.com and see our U.S. licensee (Alaven Consumer Health) site at www.travelan.org
Description: Oral caplet containing antibodies to Enterotoxigenic E. coli bacteria (ETEC)
Indication: Travellers’ Diarrhoea
Scientific Background
Travellers’ Diarrhoea, most commonly caused by Enterotoxigenic E. coli (ETEC) (Robins-Browne 2006), is a major problem for travelers to tropical regions. Anadis’ Travelan™ anti-ETEC antibody-containing caplet is taken regularly while a traveler is in a risky situation to prevent Travellers’ Diarrhoea.
Antibodies against outer bacterial structures found in the formulation have been shown in several placebo controlled clinical trials to prevent Travellers’ Diarrhoea caused by ETEC. These bacteria-specific antibodies block the attachment of Enterotoxigenic E. coli (ETEC) to the mucosal cells of the small intestine so the bacteria cannot introduce damaging toxins into these cells.
See also a special website: www.travelan.com and see our U.S. licensee (Alaven Consumer Health) site at www.travelan.org
Description: Oral caplet containing antibodies to Enterotoxigenic E. coli bacteria (ETEC)
Indication: Travellers’ Diarrhoea
Scientific Background
Travellers’ Diarrhoea, most commonly caused by Enterotoxigenic E. coli (ETEC) (Robins-Browne 2006), is a major problem for travelers to tropical regions. Anadis’ Travelan™ anti-ETEC antibody-containing caplet is taken regularly while a traveler is in a risky situation to prevent Travellers’ Diarrhoea.
Antibodies against outer bacterial structures found in the formulation have been shown in several placebo controlled clinical trials to prevent Travellers’ Diarrhoea caused by ETEC. These bacteria-specific antibodies block the attachment of Enterotoxigenic E. coli (ETEC) to the mucosal cells of the small intestine so the bacteria cannot introduce damaging toxins into these cells.
The product is
marketed globally by Immuron and is licensed for U.S. marketing to
Alaven Consumer Health. U.S. sales were initiated on March 2009.
Publications (Click to view in PDF format)
Robins-Browne,
Professor Roy. "Treatment and prevention of travellers’ diarrhoea" The
Australian Journal of Pharmacy Vol. 87, December 2006
Hammarstrom and Weiner , 2008. Targeted Antibodies in Dairy-Based Products. In Bioactive Componets of Milk, Bosze,Z (ed), Springer, pp 321-343.